Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab in routine clinical practice for diabetic macular edema in Japan
jRCT1080223554Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2017
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ranibizumab in diabetic macular edema (DME), sponsored by Novartis. Started Jun 2017; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on jRCT1080223554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223554.